Citadel Advisors’s HealthCor Catalio Acquisition Corp. Class A Ordinary Shares HCAQ Stock Holding History

Citadel Advisors’s Portfolio HCAQ Stock Details HCAQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-653,783	Closed	-$6.47M	–	15412
2021 Q3	$6.47M	Sell	653,783 -30,343	-4%	-$300K	﹤0.01%	3829
2021 Q2	$6.74M	Buy	684,126 +4,217	+0.6%	+$41.7K	﹤0.01%	3822
2021 Q1	$6.8M	Buy	+679,909	New	+$6.97M	﹤0.01%	3648

Citadel Advisors's HCAQ Position: Q4 2021 in Review

Citadel Advisors sold out of HealthCor Catalio Acquisition Corp. Class A Ordinary Shares (HCAQ) in Q4 2021, closing a stake of 653,783 shares — an estimated $6.47M sold.

Citadel Advisors first reported a position in HCAQ in Q1 2021 and held it in 3 quarters. The position peaked at $6.8M in Q1 2021. 0 funds tracked by Wall St. Rank hold HCAQ as of Q4 2021.

Citadel Advisors reported no remaining HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position as of Q4 2021 after selling out during the quarter.
Citadel Advisors sold 653,783 HealthCor Catalio Acquisition Corp. Class A Ordinary Shares shares in Q4 2021, an estimated $6.47M.
Citadel Advisors first reported a position in HealthCor Catalio Acquisition Corp. Class A Ordinary Shares in Q1 2021 and held it in 3 quarters.
Citadel Advisors's HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position peaked at $6.8M in Q1 2021.
0 funds tracked by Wall St. Rank held HealthCor Catalio Acquisition Corp. Class A Ordinary Shares as of Q4 2021.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.